Ramsey B - Search Results

1

Disposition of drugs in cystic fibrosis. I. Sulfamethoxazole and trimethoprim.

Hutabarat RM, Unadkat JD, Sahajwalla C, McNamara S, Ramsey B, Smith AL. Hutabarat RM, et al. Among authors: ramsey b. Clin Pharmacol Ther. 1991 Apr;49(4):402-9. doi: 10.1038/clpt.1991.47. Clin Pharmacol Ther. 1991. PMID: 2015729

2

Impact of sinusitis in cystic fibrosis.

Ramsey B, Richardson MA. Ramsey B, et al. J Allergy Clin Immunol. 1992 Sep;90(3 Pt 2):547-52. doi: 10.1016/0091-6749(92)90183-3. J Allergy Clin Immunol. 1992. PMID: 1527348 Review.

3

Probenecid pharmacokinetics in cystic fibrosis.

Weber A, de Groot R, Ramsey B, Williams-Warren J, Smith A. Weber A, et al. Among authors: ramsey b. Dev Pharmacol Ther. 1991;16(1):7-12. Dev Pharmacol Ther. 1991. PMID: 1879255

4

Pharmacokinetics of ticarcillin in patients with cystic fibrosis: a controlled prospective study.

de Groot R, Hack BD, Weber A, Chaffin D, Ramsey B, Smith AL. de Groot R, et al. Among authors: ramsey b. Clin Pharmacol Ther. 1990 Jan;47(1):73-8. doi: 10.1038/clpt.1990.11. Clin Pharmacol Ther. 1990. PMID: 2295222

5

Endobronchial infection in cystic fibrosis.

Smith AL, Ramsey B, Redding G, Haas J. Smith AL, et al. Among authors: ramsey b. Acta Paediatr Scand Suppl. 1989;363:31-6. doi: 10.1111/apa.1989.78.s363.31. Acta Paediatr Scand Suppl. 1989. PMID: 2701922 Review.

6

Tobramycin dosage recommendation in patients with cystic fibrosis.

Davis RL, Mendelman P, Ramsey B, Smith AL. Davis RL, et al. Among authors: ramsey b. Infection. 1989 Jan-Feb;17(1):41. doi: 10.1007/BF01643502. Infection. 1989. PMID: 2921090 No abstract available.

7

Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis.

Smith AL, Redding G, Doershuk C, Goldmann D, Gore E, Hilman B, Marks M, Moss R, Ramsey B, Rubio T, et al. Smith AL, et al. Among authors: ramsey b. J Pediatr. 1988 Apr;112(4):547-54. doi: 10.1016/s0022-3476(88)80165-3. J Pediatr. 1988. PMID: 3127569 Free article.

8

Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum.

Mendelman PM, Smith AL, Levy J, Weber A, Ramsey B, Davis RL. Mendelman PM, et al. Among authors: ramsey b. Am Rev Respir Dis. 1985 Oct;132(4):761-5. doi: 10.1164/arrd.1985.132.4.761. Am Rev Respir Dis. 1985. PMID: 3931522

9

Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study.

Levy J, Smith AL, Koup JR, Williams-Warren J, Ramsey B. Levy J, et al. Among authors: ramsey b. J Pediatr. 1984 Jul;105(1):117-24. doi: 10.1016/s0022-3476(84)80375-3. J Pediatr. 1984. PMID: 6376743 Clinical Trial.

10

Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum.

Levy J, Smith AL, Kenny MA, Ramsey B, Schoenknecht FD. Levy J, et al. Among authors: ramsey b. J Infect Dis. 1983 Dec;148(6):1069-76. doi: 10.1093/infdis/148.6.1069. J Infect Dis. 1983. PMID: 6418829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters